These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18819687)

  • 1. [Alzheimer's disease: therapeutic perspectives].
    Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
    Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
    Franke AG; Lieb K; Fellgiebel A
    Fortschr Neurol Psychiatr; 2009 Jun; 77(6):326-33. PubMed ID: 19504422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saving the mind faces high hurdles.
    Travis J
    Science; 2005 Jul; 309(5735):731. PubMed ID: 16051787
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapies for Alzheimer's disease.
    Melnikova I
    Nat Rev Drug Discov; 2007 May; 6(5):341-2. PubMed ID: 17539055
    [No Abstract]   [Full Text] [Related]  

  • 7. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
    Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Alzheimer's disease].
    Ishiura S; Hattori C
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(14):2179-85. PubMed ID: 15559301
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fundamental data on the pathologies amyloid and Tau in Alzheimer's disease: which therapeutic perspectives?].
    Checler F; Buée L
    Ann Pharm Fr; 2009 Mar; 67(2):136-53. PubMed ID: 19298897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Alzheimer's disease: current and future therapeutic approaches.
    Cummings JL
    Rev Neurol Dis; 2004; 1(2):60-9. PubMed ID: 16400259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of new therapeutics for Alzheimer's disease.
    Carter MD; Simms GA; Weaver DF
    Clin Pharmacol Ther; 2010 Oct; 88(4):475-86. PubMed ID: 20811351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular pathology and therapeutics in Alzheimer's disease: amyloid beta-protein as a therapeutic target].
    Ohyagi Y
    Fukuoka Igaku Zasshi; 2006 Sep; 97(9):261-8. PubMed ID: 17134029
    [No Abstract]   [Full Text] [Related]  

  • 14. Hopes remain for an Alzheimer's vaccine.
    Schenk D
    Nature; 2004 Sep; 431(7007):398. PubMed ID: 15385984
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Alzheimer's disease].
    Bombois S; Lebert F; Vellas B; Pasquier F
    Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future therapy in Alzheimer's disease.
    van Marum RJ
    Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perspectives in immunotherapy of Alzheimer's disease].
    Rossi G
    Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New therapeutic options in Alzheimer's disease].
    García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
    Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease.
    Li C; Ebrahimi A; Schluesener H
    Ageing Res Rev; 2013 Jan; 12(1):116-40. PubMed ID: 22982398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.